Literature DB >> 24020075

A problem of persistence: still more questions than answers?

Nathalie Q Balaban1, Kenn Gerdes, Kim Lewis, John D McKinney.   

Abstract

The current antibiotic resistance crisis has led to increased pressure to prioritize strategies to tackle the issue, with a strong focus being placed on the development of novel antimicrobials. However, one major obstacle that is often overlooked is persister cells, which are refractory to antibiotic treatment. Tackling persistence is a challenge because these cell types are extremely difficult to study and, consequently, little is known about their physiology and the factors that lead to their emergence. Here, four experts contemplate the main physiological features that define persistence and the implications of persistence for antibiotic treatment regimens, and consider what the study of bacterial persistence has taught us about the heterogeneity of bacterial populations.

Mesh:

Substances:

Year:  2013        PMID: 24020075     DOI: 10.1038/nrmicro3076

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  26 in total

1.  Bacterial persistence as a phenotypic switch.

Authors:  Nathalie Q Balaban; Jack Merrin; Remy Chait; Lukasz Kowalik; Stanislas Leibler
Journal:  Science       Date:  2004-08-12       Impact factor: 47.728

2.  Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence.

Authors:  Eitan Rotem; Adiel Loinger; Irine Ronin; Irit Levin-Reisman; Chana Gabay; Noam Shoresh; Ofer Biham; Nathalie Q Balaban
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 3.  Bacterial persistence and toxin-antitoxin loci.

Authors:  Kenn Gerdes; Etienne Maisonneuve
Journal:  Annu Rev Microbiol       Date:  2012       Impact factor: 15.500

4.  Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis.

Authors:  Lawrence R Mulcahy; Jane L Burns; Stephen Lory; Kim Lewis
Journal:  J Bacteriol       Date:  2010-10-08       Impact factor: 3.490

5.  Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.

Authors:  Tobias Dörr; Marin Vulić; Kim Lewis
Journal:  PLoS Biol       Date:  2010-02-23       Impact factor: 8.029

6.  Fundamental limits on the suppression of molecular fluctuations.

Authors:  Ioannis Lestas; Glenn Vinnicombe; Johan Paulsson
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

7.  A common mechanism of cellular death induced by bactericidal antibiotics.

Authors:  Michael A Kohanski; Daniel J Dwyer; Boris Hayete; Carolyn A Lawrence; James J Collins
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

8.  Metabolic control of persister formation in Escherichia coli.

Authors:  Stephanie M Amato; Mehmet A Orman; Mark P Brynildsen
Journal:  Mol Cell       Date:  2013-05-09       Impact factor: 17.970

9.  Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus.

Authors:  Paul J T Johnson; Bruce R Levin
Journal:  PLoS Genet       Date:  2013-01-03       Impact factor: 5.917

10.  SOS response induces persistence to fluoroquinolones in Escherichia coli.

Authors:  Tobias Dörr; Kim Lewis; Marin Vulić
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

View more
  104 in total

1.  Antibacterial drugs: Persisters come under fire.

Authors:  Christina Tobin Kåhrström
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  Drug persistence - from antibiotics to cancer therapies.

Authors:  Karl Kochanowski; Leanna Morinishi; Steven Altschuler; Lani Wu
Journal:  Curr Opin Syst Biol       Date:  2018-03-31

Review 3.  Continuum and discrete approach in modeling biofilm development and structure: a review.

Authors:  M R Mattei; L Frunzo; B D'Acunto; Y Pechaud; F Pirozzi; G Esposito
Journal:  J Math Biol       Date:  2017-07-24       Impact factor: 2.259

4.  Classic reaction kinetics can explain complex patterns of antibiotic action.

Authors:  Pia Abel Zur Wiesch; Sören Abel; Spyridon Gkotzis; Paolo Ocampo; Jan Engelstädter; Trevor Hinkley; Carsten Magnus; Matthew K Waldor; Klas Udekwu; Ted Cohen
Journal:  Sci Transl Med       Date:  2015-05-13       Impact factor: 17.956

Review 5.  Distinguishing between resistance, tolerance and persistence to antibiotic treatment.

Authors:  Asher Brauner; Ofer Fridman; Orit Gefen; Nathalie Q Balaban
Journal:  Nat Rev Microbiol       Date:  2016-04       Impact factor: 60.633

6.  In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens.

Authors:  Joran Elie Michiels; Bram Van den Bergh; Natalie Verstraeten; Maarten Fauvart; Jan Michiels
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

7.  Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.

Authors:  Nicholas D Walter; Gregory M Dolganov; Benjamin J Garcia; William Worodria; Alfred Andama; Emmanuel Musisi; Irene Ayakaka; Tran T Van; Martin I Voskuil; Bouke C de Jong; Rebecca M Davidson; Tasha E Fingerlin; Katerina Kechris; Claire Palmer; Payam Nahid; Charles L Daley; Mark Geraci; Laurence Huang; Adithya Cattamanchi; Michael Strong; Gary K Schoolnik; John Lucian Davis
Journal:  J Infect Dis       Date:  2015-03-11       Impact factor: 5.226

8.  A Universal Stress Protein That Controls Bacterial Stress Survival in Micrococcus luteus.

Authors:  Spencer Havis; Abiodun Bodunrin; Jonathan Rangel; Rene Zimmerer; Jesse Murphy; Jacob D Storey; Thinh D Duong; Brandon Mistretta; Preethi Gunaratne; William R Widger; Steven J Bark
Journal:  J Bacteriol       Date:  2019-11-20       Impact factor: 3.490

Review 9.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

Review 10.  Stable isotope biomarker breath tests for human metabolic and infectious diseases: a review of recent patent literature.

Authors:  Graham S Timmins
Journal:  Expert Opin Ther Pat       Date:  2016-08-10       Impact factor: 6.674

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.